CAR-T-Cell Shows Promise in Patients With Lymphoma of the Brain and Spinal Cord in Early Trial

Axicabtagene ciloleucel (axi-cel), a form of CAR-T therapy appears to be safe and has encouraging signs of efficacy in treating both lymphoma of the brain and spinal cord injury.

from Neuroscience News https://ift.tt/dfeHsvj